This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Intercritical Gout
and you are
between 18 and 70
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to determine if once-daily treatment with colchicine, compared to placebo, is effective in preventing gout flares in patients who are initiating therapy with allopurinol.

Provided treatments

  • Drug: Colchicine (Colcrys®)
  • Drug: placebo
  • Drug: allopurinol

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01451645. The sponsor of the trial is Regeneron Pharmaceuticals and it is looking for 82 volunteers for the current phase.
Official trial title: